South Korea
· Delayed Price · Currency is KRW Englewood Lab Statistics
Total Valuation
Englewood Lab has a market cap or net worth of KRW 246.96 billion. The enterprise value is 243.99 billion.
| Market Cap | 246.96B |
| Enterprise Value | 243.99B |
Important Dates
The next estimated earnings date is Tuesday, November 5, 2024.
| Earnings Date | Nov 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Englewood Lab has 19.87 million shares outstanding. The number of shares has increased by 0.80% in one year.
| Shares Outstanding | 19.87M |
| Shares Change (YoY) | +0.80% |
| Shares Change (QoQ) | +0.50% |
| Owned by Insiders (%) | 5.08% |
| Owned by Institutions (%) | 2.98% |
| Float | 9.11M |
Valuation Ratios
The trailing PE ratio is 11.11.
| PE Ratio | 11.11 |
| Forward PE | n/a |
| PS Ratio | 1.18 |
| PB Ratio | 1.90 |
| P/FCF Ratio | 109.87 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.48, with an EV/FCF ratio of 108.55.
| EV / Earnings | 10.93 |
| EV / Sales | 1.16 |
| EV / EBITDA | 7.48 |
| EV / EBIT | 8.70 |
| EV / FCF | 108.55 |
Financial Position
The company has a current ratio of 3.26, with a Debt / Equity ratio of 10.95.
| Current Ratio | 3.26 |
| Quick Ratio | 2.22 |
| Debt / Equity | 10.95 |
| Debt / EBITDA | 0.44 |
| Debt / FCF | 6.36 |
| Interest Coverage | 46.76 |
Financial Efficiency
Return on equity (ROE) is 18.93% and return on invested capital (ROIC) is 13.33%.
| Return on Equity (ROE) | 18.93% |
| Return on Assets (ROA) | 10.98% |
| Return on Capital (ROIC) | 13.33% |
| Revenue Per Employee | 1.18B |
| Profits Per Employee | 125.44M |
| Employee Count | 178 |
| Asset Turnover | 1.32 |
| Inventory Turnover | 4.21 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +5.86% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +5.86% |
| 50-Day Moving Average | 17,144.20 |
| 200-Day Moving Average | 15,954.70 |
| Relative Strength Index (RSI) | 38.99 |
| Average Volume (20 Days) | 254,451 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Englewood Lab had revenue of KRW 210.19 billion and earned 22.33 billion in profits. Earnings per share was 1,118.59.
| Revenue | 210.19B |
| Gross Profit | 48.30B |
| Operating Income | 28.05B |
| Pretax Income | 31.06B |
| Net Income | 22.33B |
| EBITDA | 32.61B |
| EBIT | 28.05B |
| Earnings Per Share (EPS) | 1,118.59 |
Balance Sheet
The company has 17.26 billion in cash and 14.29 billion in debt, giving a net cash position of 2.97 billion or 149.41 per share.
| Cash & Cash Equivalents | 17.26B |
| Total Debt | 14.29B |
| Net Cash | 2.97B |
| Net Cash Per Share | 149.41 |
| Equity (Book Value) | 130.47B |
| Book Value Per Share | 6,533.14 |
| Working Capital | 90.81B |
Cash Flow
In the last 12 months, operating cash flow was 7.65 billion and capital expenditures -5.40 billion, giving a free cash flow of 2.25 billion.
| Operating Cash Flow | 7.65B |
| Capital Expenditures | -5.40B |
| Free Cash Flow | 2.25B |
| FCF Per Share | 113.13 |
Margins
Gross margin is 22.98%, with operating and profit margins of 13.34% and 10.62%.
| Gross Margin | 22.98% |
| Operating Margin | 13.34% |
| Pretax Margin | 14.78% |
| Profit Margin | 10.62% |
| EBITDA Margin | 15.51% |
| EBIT Margin | 13.34% |
| FCF Margin | 1.07% |
Dividends & Yields
Englewood Lab does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 9.27% |
| Buyback Yield | -0.80% |
| Shareholder Yield | -0.80% |
| Earnings Yield | 9.00% |
| FCF Yield | 0.91% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |